211 related articles for article (PubMed ID: 29352660)
1. Clinical significance of MUC13 in pancreatic ductal adenocarcinoma.
Khan S; Zafar N; Khan SS; Setua S; Behrman SW; Stiles ZE; Yallapu MM; Sahay P; Ghimire H; Ise T; Nagata S; Wang L; Wan JY; Pradhan P; Jaggi M; Chauhan SC
HPB (Oxford); 2018 Jun; 20(6):563-572. PubMed ID: 29352660
[TBL] [Abstract][Full Text] [Related]
2. Linc00675 is a novel marker of short survival and recurrence in patients with pancreatic ductal adenocarcinoma.
Li DD; Fu ZQ; Lin Q; Zhou Y; Zhou QB; Li ZH; Tan LP; Chen RF; Liu YM
World J Gastroenterol; 2015 Aug; 21(31):9348-57. PubMed ID: 26309360
[TBL] [Abstract][Full Text] [Related]
3. MUC13 interaction with receptor tyrosine kinase HER2 drives pancreatic ductal adenocarcinoma progression.
Khan S; Sikander M; Ebeling MC; Ganju A; Kumari S; Yallapu MM; Hafeez BB; Ise T; Nagata S; Zafar N; Behrman SW; Wan JY; Ghimire HM; Sahay P; Pradhan P; Chauhan SC; Jaggi M
Oncogene; 2017 Jan; 36(4):491-500. PubMed ID: 27321183
[TBL] [Abstract][Full Text] [Related]
4. Fascin is regulated by slug, promotes progression of pancreatic cancer in mice, and is associated with patient outcomes.
Li A; Morton JP; Ma Y; Karim SA; Zhou Y; Faller WJ; Woodham EF; Morris HT; Stevenson RP; Juin A; Jamieson NB; MacKay CJ; Carter CR; Leung HY; Yamashiro S; Blyth K; Sansom OJ; Machesky LM
Gastroenterology; 2014 May; 146(5):1386-96.e1-17. PubMed ID: 24462734
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-145 targets MUC13 and suppresses growth and invasion of pancreatic cancer.
Khan S; Ebeling MC; Zaman MS; Sikander M; Yallapu MM; Chauhan N; Yacoubian AM; Behrman SW; Zafar N; Kumar D; Thompson PA; Jaggi M; Chauhan SC
Oncotarget; 2014 Sep; 5(17):7599-609. PubMed ID: 25277192
[TBL] [Abstract][Full Text] [Related]
6. Integrated expression profiling of potassium channels identifys KCNN4 as a prognostic biomarker of pancreatic cancer.
Jiang S; Zhu L; Yang J; Hu L; Gu J; Xing X; Sun Y; Zhang Z
Biochem Biophys Res Commun; 2017 Dec; 494(1-2):113-119. PubMed ID: 29050937
[TBL] [Abstract][Full Text] [Related]
7. Expression of kallikrein-related peptidase 7 predicts poor prognosis in patients with unresectable pancreatic ductal adenocarcinoma.
Iakovlev V; Siegel ER; Tsao MS; Haun RS
Cancer Epidemiol Biomarkers Prev; 2012 Jul; 21(7):1135-42. PubMed ID: 22573795
[TBL] [Abstract][Full Text] [Related]
8. Expression of SNAIL in accompanying PanIN is a key prognostic indicator in pancreatic ductal adenocarcinomas.
Fujiwara S; Saiki Y; Ishizawa K; Fukushige S; Yamanaka M; Sato M; Ishida M; Motoi F; Unno M; Horii A
Cancer Med; 2019 Apr; 8(4):1671-1678. PubMed ID: 30791220
[TBL] [Abstract][Full Text] [Related]
9. Downregulation of RPL15 may predict poor survival and associate with tumor progression in pancreatic ductal adenocarcinoma.
Yan TT; Fu XL; Li J; Bian YN; Liu DJ; Hua R; Ren LL; Li CT; Sun YW; Chen HY; Fang JY; Hong J
Oncotarget; 2015 Nov; 6(35):37028-42. PubMed ID: 26498693
[TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of hepatocyte growth factor activator inhibitor type 1 (HAI-1) immunoreactivity in pancreatic ductal adenocarcinoma.
Sakugawa C; Haruyama Y; Tanaka H; Fukushima T; Kawaguchi M; Kataoka H
BMC Res Notes; 2017 Dec; 10(1):674. PubMed ID: 29202869
[TBL] [Abstract][Full Text] [Related]
11. Aberrant expression of MUC3 and MUC4 membrane-associated mucins and sialyl Le(x) antigen in pancreatic intraepithelial neoplasia.
Park HU; Kim JW; Kim GE; Bae HI; Crawley SC; Yang SC; Gum JR; Batra SK; Rousseau K; Swallow DM; Sleisenger MH; Kim YS
Pancreas; 2003 Apr; 26(3):e48-54. PubMed ID: 12657964
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of fibroblast growth factor receptor 4 in high-grade pancreatic intraepithelial neoplasia and pancreatic ductal adenocarcinoma.
Motoda N; Matsuda Y; Onda M; Ishiwata T; Uchida E; Naito Z
Int J Oncol; 2011 Jan; 38(1):133-43. PubMed ID: 21109934
[TBL] [Abstract][Full Text] [Related]
13. Identification of ANXA1 as a lymphatic metastasis and poor prognostic factor in pancreatic ductal adenocarcinoma.
Liu QH; Shi ML; Bai J; Zheng JN
Asian Pac J Cancer Prev; 2015; 16(7):2719-24. PubMed ID: 25854353
[TBL] [Abstract][Full Text] [Related]
14. DEK protein overexpression predicts poor prognosis in pancreatic ductal adenocarcinoma.
Sun J; Bi F; Yang Y; Zhang Y; Jin A; Li J; Lin Z
Oncol Rep; 2017 Feb; 37(2):857-864. PubMed ID: 27959420
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of B2M and loss of ALK7 expression are associated with invasion, metastasis, and poor-prognosis of the pancreatic ductal adenocarcinoma.
Liu C; Yang Z; Li D; Liu Z; Miao X; Yang L; Zou Q; Yuan Y
Cancer Biomark; 2015; 15(6):735-43. PubMed ID: 26406402
[TBL] [Abstract][Full Text] [Related]
16. Decreased TIP30 expression predicts poor prognosis in pancreatic cancer patients.
Guo S; Jing W; Hu X; Zhou X; Liu L; Zhu M; Yin F; Chen R; Zhao J; Guo Y
Int J Cancer; 2014 Mar; 134(6):1369-78. PubMed ID: 24037692
[TBL] [Abstract][Full Text] [Related]
17. Comparison of ILK and ERP29 expressions in benign and malignant pancreatic lesions and their clinicopathological significances in pancreatic ductal adenocarcinomas.
Zhang K; Yao H; Yang Z; Li D; Yang L; Zou Q; Yuan Y; Miao X
Clin Transl Oncol; 2016 Apr; 18(4):352-9. PubMed ID: 26887611
[TBL] [Abstract][Full Text] [Related]
18. Elevated L1CAM expression in precursor lesions and primary and metastastic tissues of pancreatic ductal adenocarcinoma.
Bergmann F; Wandschneider F; Sipos B; Moldenhauer G; Schniewind B; Welsch T; Schirrmacher P; Klöppel G; Altevogt P; Schäfer H; Sebens Müerköster S
Oncol Rep; 2010 Oct; 24(4):909-15. PubMed ID: 20811670
[TBL] [Abstract][Full Text] [Related]
19. Nuclear expression of Y-box binding protein-1 is associated with poor prognosis in patients with pancreatic cancer and its knockdown inhibits tumor growth and metastasis in mice tumor models.
Shinkai K; Nakano K; Cui L; Mizuuchi Y; Onishi H; Oda Y; Obika S; Tanaka M; Katano M
Int J Cancer; 2016 Jul; 139(2):433-45. PubMed ID: 26939718
[TBL] [Abstract][Full Text] [Related]
20. Gene expression profiles in pancreatic intraepithelial neoplasia reflect the effects of Hedgehog signaling on pancreatic ductal epithelial cells.
Prasad NB; Biankin AV; Fukushima N; Maitra A; Dhara S; Elkahloun AG; Hruban RH; Goggins M; Leach SD
Cancer Res; 2005 Mar; 65(5):1619-26. PubMed ID: 15753353
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
